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ABSTRACT: Silk nanoparticles have demonstrated utility across a range of
biomedical applications, especially as drug delivery vehicles. Their
fabrication by bottom-up methods such as nanoprecipitation, rather than
top-down manufacture, can improve critical nanoparticle quality attributes.
Here, we establish a simple semi-batch method using drop-by-drop
nanoprecipitation at the lab scale that reduces special-cause variation and
improves mixing efficiency. The stirring rate was an important parameter
affecting nanoparticle size and yield (400 < 200 < 0 rpm), while the initial
dropping height (5.5 vs 7.5 cm) directly affected nanoparticle yield. Varying
the nanoparticle standing time in the mother liquor between 0 and 24 h did
not significantly affect nanoparticle physicochemical properties, indicating
that steric and charge stabilizations result in high-energy barriers for nanoparticle growth. Manufacture across all tested formulations
achieved nanoparticles between 104 and 134 nm in size with high β-sheet content, spherical morphology, and stability in aqueous
media for over 1 month at 4 °C. This semi-automated drop-by-drop, semi-batch silk desolvation offers an accessible, higher-
throughput platform for standardization of parameters that are difficult to control using manual methodologies.
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1. INTRODUCTION
The mulberry silk produced by the Bombyx mori silkworm is
one of the most extensively studied silks, with ancient and far-
reaching applications ranging from domestic to medical
textiles.1,2 The ability to regenerate silk fibroin protein from
the silk cocoon has realized an advent of new material formats
with adjustable physical properties; most notable among these
formats are porous scaffolds,3 hydrogels,4 films,5 and particles.6
Silk fibroin offers several exploitable characteristics, including
broad biocompatibility and biodegradability,5,7 low immuno-
genicity,5 and the presence of reactive amino acids amenable to
chemical modification.8 This amenability makes reverse-
engineered silk a promising precursor for clinical applica-
tions,1,4 as evidenced by the granting in 2019 of the first FDA
approval for a regenerated silk hydrogel for human vocal fold
reinforcement (Silk Voice, Sofregen Medical Inc., Medford,
MA).9
B. mori silk fibroin is a structural protein composed of a light
(≈26 kDa)1 and a heavy chain (≈391 kDa),1 which are linked
by a disulfide bond.1 The heavy chain has a block copolymer
sequence of short hydrophilic amorphous regions interspersed
with long hydrophobic (GAGAGX)n and (GAGAGY)n
residues.1 These hydrophobic motifs, which are capable of β-
sheet self-assembly and constitute over 50% of the primary
structure, impart high mechanical strength to the fiber.5 Silk is
a natural biopolymer with metastable tertiary structures;
therefore, the structure of silk-based materials can be tuned
to their desired function by modifying their crystallinity1,3,4,10
and hierarchical composition.11
This structural versatility, coupled with the amphiphilic
nature of silk, also permits silk to undergo a variety of favorable
intermolecular interactions with lipophilic and hydrophilic
therapeutic payloads3,12 by in situ12 or postsynthetic
loading.12−14 These interactions can also stabilize synthetic
drugs3,12 and biological molecules3,12 by surface adsorption or
encapsulation, thereby sterically shielding a drug cargo from
biological clearance. The drug release behavior can be designed
according to a tissue-specific stimulus to improve efficacy and
reduce off-target effects while preserving drug structure and
activity.3,12,15 Silk nanoparticles are especially suited for drug
targeting of solid tumors as these nanoparticles exhibit
increased drug release at low pH,6,8 which is a signature of
tumor environments. In addition, silk nanoparticles have
shown desirable critical quality attributes, including in vitro
endocytosis-mediated uptake,14 lysosomotropic drug release,16
and proteolysis,16,17 which indicate their value as anticancer
nanomedicines.
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Preparation of silk particles of submicron size (25−180 nm)
can be achieved by six major bottom-up methods (reviewed
previously18): capillary microdot printing,19 desolva-
tion,8,13,14,20 supercritical CO2
21 and electrospraying,22 emulsi-
fication,23 and ionic liquid dissolution.24 Among these
methods, desolvation provides one of the most accessible
and least energy-intensive lab-scale methods and is commonly
used for the manufacture of protein nanoparticles.25 Desolva-
tion of silk is a nanoprecipitation process whereby an aqueous
silk solution is mixed with a water-miscible organic solvent in
which the heavy-chain hydrophilic blocks have low solubility
(e.g. isopropanol and acetone). This process has no require-
ment for method-specific, expensive apparatus18 and produces
silk nanoparticles with cores enriched in β-sheet structures
without the need for further chemical cross-linking steps.
Currently, optimized lab-scale desolvation methodology uses
a semi-batch format consisting of a manual drop-by-drop
addition of 3−5% w/v silk into at least a 200% v/v excess of
the organic antisolvent.8,13,14 In comparison to batch
processes, where an empty reactor is charged with all species
simultaneously, semi-batch desolvation is defined by the feed
of the solute into a vessel precharged with an antisolvent or
vice versa.26 Semi-batch nanoprecipitation can be scaled up
from the bench,26 with the process further aided by
computational simulations.27,28 However, when compared to
pilot-scale operations, the manual method suffers from special-
cause variations in flow rate, droplet size, and dropping height.
Additionally, although particle size and polydispersity are
controlled by rapid mixing,26,27 which is facilitated by
agitation,26,28 stirring is not a common practice in manual
silk desolvation procedures.
Designing procedures, which reduce processing times and
batch-to-batch variability, will aid the progress of pharmaceut-
ical products from the bench to the market.4,12 The aim of the
current study was to establish a simple, semi-automated, and
higher-throughput drop-by-drop technique for semi-batch silk
nanoprecipitation. We investigated the impact of several
process parameters, including stirring rate and standing time,
on the physicochemical properties (e.g. particle size,
polydispersity, zeta potential, stability, secondary structure,
morphology, and yield) of the resulting silk nanoparticles.
2. MATERIALS AND METHODS
Unless otherwise stated, studies were conducted at 18−22 °C. All
reagents and solvents were acquired from Acros Organics or Sigma-
Aldrich at >98% purity, unless otherwise stated, and utilized without
additional purification.
2.1. Regeneration of B. mori Silk. Silk fibroin was extracted
from B. mori cocoons, as described elsewhere.13 Briefly, B. mori
cocoons were cut into approximately 5 × 5 mm2 sections and boiled,
with manual stirring, in 0.02 M aqueous Na2CO3 (2 L) at 98−105 °C
for 1 h. Degummed silk fibers were rinsed in ultrapure H2O (1 L)
three times for 0.33 h each. The silk was then dried for at least 24 h at
room temperature.
Dry silk fibers were dissolved in a 9.3 M aqueous LiBr solution at
60 °C for 4 h to give a 25% w/v silk solution. The silk solution was
dialyzed (molecular weight cutoff 3500 g mol−1, Slide-A-Lyzer,
Thermo Scientific, Rockford, IL) against ultrapure H2O (1 L) for 48 h
and then purified by centrifugation over four cycles, each for 0.33 h at
3000g and 5 °C (Jouan BR4i centrifuge equipped with an S40 swing
rotor). Silk concentrations were determined gravimetrically over 24 h
at 60 °C and then adjusted to 3% w/v with ultrapure H2O.
2.2. General Drop-By-Drop Manufacture of Silk Nano-
particles in Semi-Batch Format. Silk nanoparticles were
manufactured at room temperature using a syringe pump (Harvard
Apparatus 22, Holliston, MA) equipped with a BD PLASTIPACK
syringe and blunt needle (23G × 0.25″) (Figure 1). Inclination of the
syringe pump was 0−0.1°. The isopropanol antisolvent was added to a
short-neck round-bottom flask (to give a final 5:1 v/v ratio of
isopropanol:silk). A 3% w/v silk solution was then added drop by
drop at a rate of 1 mL min−1 (≈27 drops min−1 and 37 μL min−1).
The resulting suspensions were incubated at room temperature for the
designated time and then transferred to polypropylene ultra-
centrifugation tubes made up to 43 mL with ultrapure H2O and
centrifuged at 48,400g for 2 h at 4 °C (Beckmann Coulter Avanti J-E
equipped with JA-20 rotor). The supernatant was aspirated, and the
pellet was resuspended in ultrapure H2O (20 mL) and sonicated twice
for 30 s at 30% amplitude with a Sonoplus HD 2070 sonicator
(ultrasonic homogenizer, Bandelin, Berlin, Germany). An additional
volume of ultrapure H2O (23 mL) was added, and the centrifugation,
washing, and resuspension steps were repeated twice more. The final
pellet was collected and resuspended in 2−3 mL water. This final silk
Figure 1. Nanoprecipitation workflow in a drop-by-drop open system for the preparation of silk nanoparticles. The five processing steps are (1)
loading of a bubble-free 3% w/v aqueous silk solution into a syringe equipped with a blunt needle, (2) the relative positions of the needle and
round-bottom flask, (3) the flow rate control of silk solution at 1 mL min−1, (4) the stirring rate during addition, and (5) the nanoparticle standing
time in the mother liquor following completion of silk addition.
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nanoparticle suspension was stored at 4 °C until use. Unless stated
otherwise, each experiment was repeated in triplicate using three
different aqueous silk precursor stock solutions.
Calculations for needle residence time and shear rate are based on
the literature dynamic viscosity (27 mPa s) of the regenerated 3%
aqueous silk29 and density (1.02 g mL−1) calculated herein for the 3%
w/v aqueous silk solution and assumed Newtonian flow.29 Reynold’s
number was estimated as 2 using the internal diameter of the needle30
(0.33 mm) and indicated laminar flow. An upper limit of the
residence time was estimated using the linear velocity (1.94 mm s−1)
and the needle length.31 The maximum shear rate was taken as the
wall shear rate, and for simplicity, the shear rate calculations used the
geometry of a straight cylinder. Calculations for the 3 and 10 mL
syringes used in the study were undertaken similarly using the internal
diameters as stated by the manufacturer.
2.2.1. Reproducibility of Semi-Automated Silk Nanoparticle
Manufacture. Silk nanoparticles were manufactured in a 10 mL flask
at a 6 mL total volume (Figure 1). Silk was added from a height of 5.5
cm from the bottom of the isopropanol meniscus. The mother liquor
suspension was then incubated for 2 h before purification. This
procedure was repeated a further 15 times using five silk precursor
solutions.
2.2.2. Effect of Stirring Rate on Manufacture and Silk
Nanoparticle Properties. Silk nanoparticles were manufactured in a
10 mL flask at a 6 mL total volume (Figure 1). Silk was added from a
height of 7.5 cm from the bottom of the isopropanol meniscus, and
stirring was accomplished with an egg-shaped stir bar (15 × 6 mm) at
200 and 400 rpm. The mother liquor suspension was then incubated
for 2 h before purification. This procedure was repeated in triplicate
using three silk precursor solutions.
2.2.3. Effect of Standing Time on Manufacture and Silk
Nanoparticle Properties. Silk nanoparticles were manufactured in a
50 mL flask at a 36 mL total volume. Silk was added from a height of
7.5 cm from the bottom of the isopropanol meniscus with stirring at
400 rpm with an egg-shaped stir bar (15 × 6 mm). An aliquot (6 mL)
was taken immediately following complete addition of the silk
precursor, and stirring was stopped. Further aliquots (6 mL) were
taken at 2.7, 5.5, 8.5, 11.5, and 24 h following stirring for 0.02 h at 400
rpm to ensure suspension homogeneity. This procedure was repeated
in triplicate using three silk precursor solutions.
2.3. Yield of Silk Nanoparticles. The nanoparticle concen-
trations were determined by recording the total mass of the
suspension in a preweighed centrifuge tube. A known mass of each
suspension was then frozen at −80 °C for 5 h in preweighed
microcentrifuge tubes, followed by freeze-drying (Christ Epsilon 1−4,
Martin Christ Gefriertrocknungsanlagen GmbH, Osterode, Germany)
for 24 h at −10 °C and 0.14 mbar. The dry mass was recorded, and
the yield was calculated using eq 1
yield/%
particle concentration (% w/w) mass (mg)
silk concentration (% w/v) volume (mL)
100%
=
×
×
× (1)
This process was repeated in duplicate and the average yield was
reported, and the freeze-dried samples were stored in a vacuum
desiccator until use.
2.4. Silk Nanoparticle Physicochemical Characterization
and Stability in Water. The size (Z-average of the hydrodynamic
diameter), polydispersity, and zeta potential of silk nanoparticles were
determined as described elsewhere.32 Briefly, silk nanoparticles were
analyzed in ultrapure H2O at 25 °C by dynamic light scattering (DLS)
(Zetasizer Nano-ZS Malvern Instrument, Worcestershire, U.K.).
Unless otherwise stated, the samples were vortexed for 20 s and
sonicated twice at 30% amplitude for 30 s prior to measurement.
Refractive indices of 1.33 and 1.60 for H2O and protein, respectively,
were used for particle size measurement. All analyses were conducted
in triplicate.
The particle size and zeta potential of silk nanoparticles generated
in the stirring studies were determined on days 0, 10, 18, 24, 28, 35,
and 42 by DLS. The particle size and zeta potential of silk
nanoparticles generated in standing time studies were determined at
days 0, 42, and 63 by DLS. The silk nanoparticles from all studies
were stored at 4 °C. At t > 0 days, the silk nanoparticles were vortexed
for 20 s before size and zeta potential analysis.
2.5. Secondary Structure Measurements of Silk Nano-
particles. Air-dried silk films and freeze-dried silk were used as silk
I structure references, while autoclaved silk films and silk films treated
with 70% v/v ethanol/ultrapure H2O were used as positive controls
for silk II structure. Silk films, powders, and nanoparticles were
analyzed by Fourier transform infrared spectroscopy (FTIR) on an
ATR-equipped TENSOR II FTIR spectrometer (Bruker Optik
GmbH, Ettlingen, Germany). Each nanoparticle and freeze-dried
silk sample was flash-frozen at −80 °C for at least 5 h and then
lyophilized for 24 h. Each FTIR measurement was run for 128 scans
at a 4 cm−1 resolution in absorption mode over the wavenumber
range of 400−4000 cm−1 and corrected for atmospheric absorption
using Opus (Bruker Optik GmbH, Ettlingen, Germany). The amide I
regions of the FTIR spectra were analyzed in OriginLab 19b
(Northampton, Massachusetts), as described elsewhere.33 The second
derivative of the background-corrected absorption spectrum was
obtained and smoothed twice using a seven-point Savitzky−Golay
function with a polynomial order of 2. A nonzero linear baseline was
interpolated between 2 and 3 of the highest points between 1600 and
1710 cm−1. Peak positions in the amide I region were then identified
using the second derivative and peaks fitted using nonlinear least
squares with a series of Gaussian curves (Figure S1). Band positions,
widths, and heights were allowed to vary, and peak area was allowed
to take any value below or equal to 0. The deconvoluted spectra were
area-normalized, and the secondary structure content was calculated
with reference to literature band assignments34,35 using the relative
areas of each band.
The correlation coefficient (R) was calculated according to
previous analyses.36 The air-dried silk film of an aqueous silk
precursor batch was used as the reference for all silk films, freeze-dried
silk, and silk nanoparticle samples. The second-derivative curves of
the absorption spectra were smoothed twice with a five-point
Savitzky−Golay function and a polynomial order of 2 and then
compared over the spectral range of 1600−1700 cm−1 using eq 2
R
x y
x y
i i
i
2
i
2
=
∑
∑ ∑ (2)
where xi and yi are the derivative values of the air-dried silk film and
sample of interest at the frequency i, respectively.
2.6. Thermal Analysis of Silk Nanoparticles. A known volume
and mass of each silk sample and freeze-dried silk control was frozen
at −80 °C for 5 h, followed by freeze-drying for 24 h at −10 °C and
0.14 mbar. First-cycle differential scanning calorimetry and
thermogravimetric analysis were carried out on the dried samples
(1.95−4.89 mg) in aluminum pans from 20 to 350 °C at a scanning
rate of 10 °C min−1 and under a nitrogen flow of 50 mL min−1 (STA
Jupiter 449, Netzsch, Geraẗebau GmbH, Germany). Thermograms
were analyzed using OriginLab 19b (Northampton, Massachusetts).
The desorption enthalpy was normalized to a corrected mass during
volatilization, as described previously.37
2.7. Scanning Electron Microscopy (SEM) of Silk Nano-
particles. Aqueous silk nanoparticle suspensions were adjusted to a
concentration of 1 mg mL−1. An aliquot (20 μL) of each sample was
then pipetted onto a silicon wafer and lyophilized for 24 h at −10 °C
and 0.14 mbar. The specimens were sputter-coated with gold using a
low-vacuum sputter coater (Agar Scientific Ltd., Essex, U.K.) and
analyzed with the secondary electron detector of an FE-SEM SU6600
instrument (Hitachi High Technologies, Krefeld, Germany) at 5 kV
and 40k magnification. The images were processed using ImageJ
v1.52n (National Institutes of Health, Bethesda, MD) and Adobe
Illustrator (Adobe, San Jose, CA).
2.8. Statistical Analyses. Data were analyzed using Microsoft
Excel 2019 (Microsoft Office 365 ProPlus Software, Redmond, WA),
Minitab (Minitab Statistical Software, State College, PA), and
GraphPad Prism 8.2.1 (GraphPad Software, La Jolla, CA). The test
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for equal variance was undertaken on multiple groups using Bartlett’s
method. Sample pairs were analyzed using Welch’s independent t-test.
Multiple groups were evaluated by one-way analysis of variance
(ANOVA), followed by Tukey’s multiple comparison post hoc test or
by the Brown−Forsythe and Welch ANOVA tests, followed by the
Dunnett T3 multiple comparison post hoc test. Silk nanoparticle
stability was evaluated by ANOVA followed by Dunnett’s post hoc
test to compare between t = 0 day control and t > 0 day samples. All
data were assumed to have normal distributions. Asterisks denote
statistical significance determined using post hoc tests as follows: *p <
0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001. Unless
otherwise specified, all data are presented as mean values ± (SD) and
the number of experimental repeats (n) is noted in each figure legend.
3. RESULTS
3.1. Silk Nanoparticle Characterization. The DLS and
mass measurement values indicated an influence of the stirring
rate on the physicochemical properties and yield of silk
nanoparticles (Figures 1 and 2). When the silk solution was
added from a height of 7.5 cm, an increase in the stirring rate
from 0 to 400 rpm significantly decreased the silk nanoparticle
size (ANOVA, p < 0.05) from 134 to 114 nm (Figure 2c).
Varying the stirring rate between 0 and 400 rpm had no
significant impact on the polydispersity or negative surface
charge, which ranged from 0.12 to 0.14 and −30 to −33 mV,
respectively (Figure 2d,e). However, increasing the stirring rate
significantly decreased the yield from 23 to 9% (ANOVA, p <
0.01) (Figure 2f).
The effect of droplet velocity on nanoparticle formation in
the absence of stirring was determined by varying the height
from which the silk solution was dropped (henceforth, initial
addition height). A decrease in the initial addition height from
7.5 cm (νdroplet ≈ 1.21 m s−1) to 5.5 cm (νdroplet ≈ 1.03 m s−1)
significantly decreased the yield of nanoparticles (t-test, p <
0.01) from 23 to 18%. By contrast, the physicochemical
properties were not affected by decreasing the initial addition
height to 5.5 cm, as the nanoparticles had an average size,
polydispersity, and zeta potential of 131 nm, 0.11, and −30
mV, respectively.
The growth of nanoparticles in the mother liquor was also
investigated by varying the nanoparticle standing time before
purification (Figure 1). Over a 24 h interval, the standing time
had no significant effect on nanoparticle physicochemical
properties or yield. Overall, the silk nanoparticle size ranged
from 104 to 116 nm, with a polydispersity ranging from 0.11 to
0.14. The negative surface charge ranged from −30 to −35
mV, and the yield varied between 9 and 15% w/w of silk
(Figure 2).
3.2. Secondary Structure Measurement. The impact of
the process conditions on silk nanoparticle secondary structure
was determined by attenuated total reflectance-FTIR (ATR-
FTIR) analysis and deconvolution of the characteristic protein
amide I band (1600−1710 cm−1) (Figure S1). Silk nano-
particle secondary structure did not vary significantly with
changes in the initial addition height, stirring rate, or
formulation standing time. For stirring and standing time
studies, the high nanoparticle β-sheet content (54−57%)
correlated with the 55% β-sheet composition measured for
autoclaved and ethanol-treated silk films, which served as
positive controls for silk II structure (Figure 3). Additionally,
the α-helix and random coil content (18−21%) of silk
nanoparticles were comparable to autoclaved (20%) and
ethanol-treated films (19%). Autoclaving provides thermal
energy to break labile bonds in the silk film, with the uptake of
water acting to plasticize the material. This directly contrasts
with nanoprecipitation, where water is removed from the silk
hydration shell. The silk nanoparticle structure from both
studies showed a significantly higher percentage of β-sheets
(ANOVA, p < 0.0001) and less α-helix and random coil
content (ANOVA, p < 0.0001) compared to the negative silk II
structure controls (air-dried silk film and freeze-dried silk
powder with 17−25% β-sheet and 47−56% α-helix and
random coil content) (Figure 3c).
The spectral correlation coefficient method of comparing
second-derivative ATR-FTIR spectra in the amide I region
(1600−1700 cm−1) was also used to measure formulation-
induced structural changes in silk nanoparticles versus those in
an air-dried silk film. Silk nanoparticle correlation coefficients
ranged from 0.27 to 0.31 and showed no significant variation
with initial addition height, stirring rate, or formulation
standing time (Figure 3c). The stirring and standing time
studies revealed a discrepancy between the correlation
coefficients of silk nanoparticles and those of the autoclaved
films (0.10) (ANOVA, p < 0.0001) and the ethanol-treated silk
films (0.18) (ANOVA, p < 0.05). This disagreement with the
band deconvolution findings could reflect offsets in the second-
derivative baselines. Regardless, the nanoprecipitation-associ-
ated β-sheet enrichment, identified by band deconvolution,
Figure 2. Impact of stirring rate and standing time on the
physicochemical properties and yield of nanoparticles produced by
drop-by-drop desolvation. (a) Schematic of the five processing
parameters used to investigate the stirring rate and (b) the standing
time for silk nanoparticle manufacture. (c) Hydrodynamic diameter,
(d) polydispersity index (PDI), (e) zeta potential, and (f) yield of silk
nanoparticles. Error bars are hidden in the bars and plot symbols
when not visible, ± SD, n = 3. Multiple groups were evaluated by one-
way analysis of variance (ANOVA), followed by Tukey’s multiple
comparison post hoc test. Asterisks denote statistical significance
determined using post hoc tests as follows: *p < 0.05 and **p < 0.01.
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was supported by the significantly lower nanoparticle
correlation coefficients compared to the negative silk II
controls of air-dried (0.95) and freeze-dried (0.92) silks
(ANOVA, p < 0.0001).
3.3. Thermal Analysis. The simultaneous thermal analysis
first-cycle results of silk nanoparticles manufactured at stirring
rates between 0 and 400 rpm and silk II negative controls are
shown in Figure 4 and Table 1. Thermogravimetric analysis
(TGA) was used to confirm differences in water content and
thermal stabilities of silk nanoparticles caused by formulation
(Figure 4). Thermograms of all silk nanoparticles and controls
showed three regions with two weight loss steps: the loss of
adsorbed and strongly bound water between 20 and 140 °C
followed by silk decomposition above 170 °C. The increase in
mass at low temperatures in TGA measurements was due to
buoyancy effects resulting from variations in air density with
heating.38 No significant differences in water content were
observed with increased stirring rate, with nanoparticles
containing 12−14% w/w water across all formulations.
Nanoparticles displayed a significantly delayed (ANOVA, p <
0.05) onset decomposition temperature ranging between 273.2
and 277.3 °C compared to the freeze-dried powder, negative
silk II control (261.4 °C). This higher stability to thermal
degradation suggests that nanoparticle structure is composed
of a higher crystalline fraction compared to amorphous, freeze-
dried silk. Nevertheless, there was no significant difference
between the decomposition temperatures of silk nanoparticles
manufactured at different stirring rates, ranging between 298.5
and 304.0 °C.
Differential scanning calorimetry (DSC) measurements
confirmed that the formulation stirring rate did not affect the
primary or secondary structure of silk nanoparticles (Figure 4).
The desorption enthalpy ranged between −207.8 and −282.7 J
g−1, and the temperature of desorption ranged from 36.1 to
43.6 °C, with no significant variation observed with stirring
rate. The water desorption-associated and final glass transitions
at 59.3 and 201.5 °C, respectively, were not identifiable for all
nanoparticle samples. The glass transition at 201.5 °C was also
shifted to a higher temperature and was less steep when
compared to that of the silk I structure (184.5 °C). This
indicates that the molecular mobility of silk molecules was
reduced upon their incorporation into the nanoparticle
structure. The crystallization exotherm (random coil to β-
sheet transition), present for the negative controls at 241.0 °C,
was absent from the nanoparticle curves. No significant
difference was noted between the decomposition temperatures
Figure 3. Changes in the stirring rate or standing time results in silk nanoparticles with comparable secondary structure. (a) Schematic of protein−
protein association and β-sheet assembly of silk fibroin during nanoprecipitation via desolvation. Silk molecules, nanoparticles, and stoichiometry of
association are not drawn to scale. (b) FTIR band assignments and schematic key. Secondary structure content of silk nanoparticles manufactured
using different (c) stirring rates and (d) standing times. Silk films treated with 70% ethanol and autoclaving to obtain high β-sheet content were
used as positive controls for silk II structure, with an untreated silk film and freeze-dried silk powder serving as negative controls. The correlation
coefficients (R) of silk nanoparticle, film, and powder second-derivative amide I spectra were calculated using the silk II negative control film as
reference, n = 3, ± SD. The correlation coefficients, total β-sheet, and α-helix and random coil contents were evaluated by one-way analysis of
variance (ANOVA), followed by Tukey’s multiple comparison post hoc test. The intermolecular β-sheet, native β-sheet, β-turn, and antiparallel
amyloid β-sheet contents were evaluated using the Brown−Forsythe and Welch ANOVA tests, followed by the Dunnett T3 multiple comparison
post hoc test.
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(ranging between 282.9 and 289.5 °C) of silk nanoparticles
manufactured at different stirring rates.
3.4. Silk Nanoparticle Aqueous Stability. The particle
size, polydispersity, and zeta potential stability of nanoparticles
manufactured with stirring rates between 0 and 400 rpm were
determined for up to 42 days. Nanoparticles manufactured
across all stirring rates showed size stability and constant
polydispersity in water for up to 42 days (Figure 5). By
contrast, the zeta potential of nanoparticles manufactured
without stirring varied significantly across 42 days. The particle
size, polydispersity, and zeta potential stability of nanoparticles
manufactured with standing times between 0 and 24 h were
also determined for up to 63 days. All formulations showed
size and polydispersity stability in water for up to 63 days
(Figure 5). The negative surface charges of silk nanoparticles
Figure 4. Representative first-cycle raw (a) thermogravimetric
analysis (TGA) thermograms and (b) differential scanning calorim-
etry (DSC) of silk nanoparticles manufactured at different stirring
rates. (c) Thermal event assignment key. Water content (%, w/w),
dehydration temperature (Td), glass-transition temperatures (Tg),
extrapolated onset temperature of crystallization and decomposition
(To), crystallization temperature (Tc), and decomposition temper-
atures (Tdec) are reported.
Table 1. First-Cycle Simultaneous Thermal Analysis Data of Silk Nanoparticles Manufactured at Different Stirring Rates
stirring rate/rpm silk II
thermal property 0 200 400 freeze-dried silk
DSC Tg/°C 59.3 ± 0.01 59.4
a 59.3a 47.7 ± 0.5
Td (DSC)/°C 39.1 ± 5.3 36.1 ± 0.3 43.6 ± 13.9 60.7 ± 8.8
ΔHd/J g−1 −207.8 ± 98.0 −266.4 ± 14.3 −239.4 ± 18.8 −276.9 ± 4.21
Tg′/°C 196.9a 206.0a 184.5 ± 0.7
To (crystallization)/°C 225.6 ± 11.1
Tc/°C 241.0 ± 0.8
ΔHc/J g−1 9.9 ± 2.3
To/°C 274.0 ± 0.3 266.6 ± 7.3 268.9 ± 9.0
Tdec/°C 289.5 ± 0.5 282.9 ± 6.1 284.2 ± 7.7 274.9 ± 0.7
b
TGA water content/% 13.0 ± 1.7 13.7 ± 2.1 12.6 ± 2.0 5.8 ± 0.8
To/°C 277.3 ± 0.2 273.2 ± 2.9 274.3 ± 3.8 198.5 ± 2.2
To′/°C 261.4 ± 2.0
Tdec/°C 299.6 ± 6.6 298.5 ± 9.0 304.0 ± 4.6 222.3 ± 13.3
Tdec′/°C 275.0 ± 2.7
an = 1. bAn altered decomposition profile was noted for one control sample.
Figure 5. Stability of silk nanoparticles manufactured in semi-batch
format by varying the stirring rates and standing times. (a)
Hydrodynamic diameter, (b) polydispersity index (PDI), and (c)
zeta potential of silk nanoparticles stored in water at 4 °C. Diluted
nanoparticle suspensions were vortex-mixed prior to DLS analysis, ±
SD, n = 3. Unless otherwise stated, silk nanoparticle stability was
evaluated by ANOVA followed by Dunnett’s post hoc test to compare
between t = 0 day control and t > 0 day samples. The PDI stability of
nanoparticles manufactured with 0 h standing times was evaluated
using the Brown−Forsythe and Welch ANOVA followed by
Dunnett’s T3 post hoc test. Asterisks denote statistical significance
for each formulation between t = 0 and t > 0 days, determined using
post hoc tests as follows: *p < 0.05 and **p < 0.01.
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after 0, 2.7, and 11.5 h standing times significantly decreased at
42 days at 4 °C and then increased.
3.5. Scanning Electron Microscopy of Silk Nano-
particles. Silk nanoparticle morphology was analyzed
qualitatively by SEM (Figure 6). Silk nanoparticles manufac-
tured with stirring rates of 200 and 400 rpm at 6 mL scale had
spherical shapes and narrow size distributions at day 24.
Nanoparticles manufactured with standing times of 0 and 24 h
at the 36 mL scale showed generally spherical morphologies
and uniform size distribution when imaged at day 55. Overall,
nanoparticles showed a coarse surface topography.
4. DISCUSSION
Silk particles have attracted increased attention for drug
delivery applications because their manufacture can be tailored
for a desired size (from nano- to microscale), crystallinity, and
surface chemistry.6,18,39 The nanoparticles produced by
desolvation are well suited to anticancer applications due to
their submicron size,8,14,16,20,32 which would allow extrava-
sation through leaky tumor vasculature,40 followed by
endocytosis and lysosomal trafficking in malignant cells.16
However, nanoparticle manufacture and drug loading have not
always translated from small-scale, bench procedures to those
following current good manufacturing practices (i.e. 21 Code
of Federal Regulations Part 210−212) in the manufacturing
sector.41,42 This has prompted the implementation of
continuous techniques,20,23,32 which can offer greater ease of
scale-up.41 One powerful approach includes microfluidic-
assisted nanoprecipitation, which uses laminar flow focusing
to achieve micromixing conditions and solvent shifting by
diffusion.20,32,41 Production can be scaled up by microfluidic-
chip parallelization or increasing channel diameters, although
working at large total volumes can cause problems due to low
production rates and the limitations of scaling imposed by
complex mixer designs. Consequently, improving the reprodu-
cibility of lab-scale methodology for semi-batch manufacture of
silk nanoparticles is still an area of much interest.
Understanding the parameters that impact silk nano-
precipitation will aid in the optimization of silk nanoparticle
physicochemical properties for in vivo performance as nano-
medicines. The consequences of varying silk stock reverse-
engineering processes20 and antisolvent species,4,32 and their
relative ratios, on the outcome of nanoprecipitation in semi-
batch43 and continuous format32 are already reported. For
example, 1 h degumming times for silk cocoons resulted in
greater molecular weight polydispersity of silk stocks and in
favorable nanoparticle size, polydispersity, and zeta potential
when compared to shorter degumming times.20 Several
research groups have also investigated the effect of the
antisolvent species used for nanoprecipitation on the resulting
nanoparticle properties,32,44 as the antisolvent molecular and
macroscopic properties contribute to the mixing conditions.
Increasing the volume ratio of the antisolvent-to-silk solution
imposes high supersaturation conditions in both semi-
batch43,44 and microfluidic formats,32 resulting in faster
nucleation and smaller nanoparticle sizes. Hence, in the
current study, the optimized formulation variables13,20,32 for
preparing silk nanoparticles were used to investigate several
little-understood preparation parameters, namely, initial
addition height, nanoparticle stirring rate, and standing time.
A semi-automated drop-by-drop procedure for silk desolva-
tion in semi-batch format was designed to replace the manual
addition of silk to organic antisolvent using a syringe or
pipette. It is probable that homogeneous silk nucleation
occurred by antisolvent-induced desolvation (Figure 3a). We
do not consider seeded crystallization as the 3% w/v silk
concentration used lay below the ≈10% w/w critical micelle
concentration29 of regenerated silk fibroin. Additionally, the
Figure 6. Scanning electron microscopy images of silk nanoparticles manufactured using (a) stirring rates of 200 and 400 rpm and (b) standing
times of 0 and 24 h. Nanoparticles manufactured at stirring rates of 200 and 400 rpm were imaged on day 24, n = 1. Nanoparticles manufactured
using standing times of 0 and 24 h were imaged at day 55, n = 1. Scale bars = 200 nm.
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silk addition rate of 1 mL min−1 ensured laminar flow in the
syringes and needle. The maximum wall shear rates in the
syringes were estimated between 55 and 261 m s−1, while the
wall shear rate in the needle was estimated as 4724 s−1.
Combined with the low residence time of 33 ms, these shear
rates would not be expected to provide sufficient work (≈105
Pa)45 for shear-induced nucleation of the silk molecules.
Silk nanoparticles were reproducibly and reliably manufac-
tured at a 6 mL scale when key processing parameters were set
at levels for optimal nanoparticle properties, as determined in
previous work.13,20,32 As unreliable nanoparticle manufacture
has been implemented in the reduced efficacy of the generic
Doxil formulation, LipoDox,41,46 one might speculate that
increasing the reproducibility of silk nanoparticle manufacture
will ultimately lead to better in vitro and in vivo therapeutic
profiling. For example, across 16 repeats using three aqueous
silk batches over 3 days, silk nanoparticles produced at a 5.5
cm initial addition height and without stirring had an average
size of 131 ± 7 nm and a low polydispersity of 0.11 ± 0.02.
The polydispersity was similar to previously reported values
obtained using the same silk concentration and silk-to-
antisolvent volumetric ratio in manual and microfluidic-
assisted methodology.8,13,20,32 Although the nanoparticle sizes
were larger than the literature values (≈100−115 nm),8,13,20,32
they lie within the optimal size range (100−200 nm) for drug
delivery vehicles.47 The nanoparticles were obtained in an
average yield of 18 ± 3%, comparing favorably with previous
reports in manual and microfluidic formats.13,32 The zeta
potential of −30 ± 2 mV was higher than previously reported
values obtained with manual silk addition.8,20 This phenom-
enon was also observed for microfluidic-assisted manufac-
ture20,32 and probably reflects different silk molecule packing
arrangements resulting from varying fluid dynamics due to the
different flask geometries between the studies.
Silk nanoparticles were highly crystalline, featuring a high β-
sheet content of 56 ± 1% and a spectral correlation coefficient
of 0.27 ± 0.03 over the amide I region, in agreement with
previous studies.20,32 Increasing the initial addition height to
7.5 cm resulted in higher droplet impact velocity and kinetic
energy, thereby causing larger disturbances in the antisolvent
and facilitating mass transfer and solvent shifting. Surprisingly,
this change did not significantly affect nanoparticle phys-
icochemical properties, although it resulted in significantly
increased yield.
The inverse relationship between nanoparticle size and
formulation stirring rate has been observed for globular protein
nanoparticles48 and polymer emulsions.49 As a nanoprecipita-
tion process, aqueous silk desolvation is fundamentally a
diffusion-limited solvent shift of water molecules from the silk
hydration shell and their replacement with isopropanol
molecules. Therefore, mixing efficiency is an important factor
that dictates nanoprecipitation outcomes, and magnetic stirring
increases the control of macro- to micromixing rates.28 In lab-
scale semi-batch manufacture, the silk nanoparticle size and
yield showed inverse dependence on the stirring rate, through
0−400 rpm (Figure 2). While stirring has been used for
desolvation of regenerated silk obtained from Antheraea
mylitta,50 we believe this is the first report highlighting the
importance of stirring rate in a semi-batch system on the
outcome of silk fibroin desolvation. When manufactured at 400
rpm stirring rate and 6 mL scale, the nanoparticle size
compared well with literature values for manual semi-batch
manufacture, which is typically conducted between 40 and 50
mL scales without stirring.8,20 It is likely that reducing the
mixing time by active stirring will result in increased
reproducibility of nanoparticle physicochemical properties
during scale-up, although experimental proof is needed.
Silk nanoprecipitation occurs during mixing with an
antisolvent in which the solubility of at least one type of
hydrophilic block is low, and this results in particle nucleation
upon supersaturation (i.e., when the silk concentration exceeds
the equilibrium solubility).25,51 Nucleation follows a minimum
Gibbs free-energy self-assembly process via protein−protein
association until a critical nucleus size is reached.51 This is then
followed by particle growth and protein conformational
changes for induced fit (Figure 3a).51 For most cases, the
general mechanism of protein−protein association is defined
by at least three steps.51 The initial steps are diffusion-limited
and occur following complete solvent−antisolvent mixing.
First, a random collision of proteins produces a nonspecific
encounter complex, which minimizes repulsive long-range
electrostatics.51 This short-lived complex can then go on to
form nuclei with favorable intermolecular interactions,
although no change in secondary structure occurs. This
process is enthalpy-driven: the establishment of new short-
range attractive forces between silk molecules offsets the
entropic loss upon incorporation into the nuclei.
The consequent reduction in protein concentration reduces
the rate of further nucleation and, for nuclei exceeding the
critical size, leads to growth by thermodynamically controlled
stepwise or aggregative mechanisms.27,52 The final step
involves a structural change between the favorable growth
intermediates and the nanoparticle-bound state to maximize
attractive intra- and intermolecular interactions. In the case of
silk fibroin, this involves conversion of random coil and α-helix
content to β-sheet structure.1,32 Across all semi-batch
formulations, as in previous microfluidic-assisted work,20,32
the mixing efficiency correlated with nanoparticle size, while
the secondary structure content and thermal stability of silk
nanoparticles remained consistent. Hence, nanoprecipitation
can be assumed to occur via diffusion-controlled association in
the regime where kR→β+ ≫ k1− (Figure 3a),51 so β-sheet
formation occurs at a faster rate than silk molecule diffusion.
Applying this assumption to silk fibroin desolvation, the high
turbulence created by increasing the stirring rate would
increase the meso- and micromixing rates, thereby reducing
the total mixing time.27,53 Consequently, nucleation rates will
increase, causing a fast reduction in supersaturation and
arresting further nucleation, thereby resulting in a growth
phase with greater homogeneity. The reduction in local silk
concentration with lower mixing times also disfavors surface-
controlled growth processes of nuclei and lowers the chance of
successful diffusion-limited collisions of silk molecules with
nuclei54 prior to structural rearrangement.
Alternatively, as the stirring rate and mixing efficiency
increased, solvent shifting from hydrated silk pockets was likely
improved prior to β-sheet enrichment. This would result in
tighter packing of the internal nanoparticle architecture.
However, variation in the stirring rate caused no significant
difference in water content or desorption enthalpy by
simultaneous thermal analysis. Furthermore, as water absorp-
tion occurs predominantly in the amorphous regions,55
variations in secondary structure would be expected. Never-
theless, β-sheet crystalline content did not vary significantly
between nanoparticle formulations, as measured by amide I
band deconvolution.32,33,36 The elevated decomposition
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temperatures, absence of crystallization exotherms, and
shallower glass-transition profiles of nanoparticles compared
to freeze-dried silk (Figure 4) reinforced the high nanoparticle
crystallinity determined by FTIR.35,56 Simultaneous thermal
analysis also showed no significant differences between the
thermal stabilities of nanoparticles manufactured with different
stirring rates. Macromolecule thermal stability is dependent on
molecular weight and length,56 so this finding indicated that
silk molecules incorporated into nanoparticles from all
formulations were of a similar weight and length distribution,
again reinforcing previous work.20
We speculate that the reduction in nanoparticle yield with
stirring is due to several factors, including silk film formation
on flask walls and insufficient g-force for the sedimentation of
smaller nanoparticles during centrifugation. Stirring at 400 rpm
resulted in the poorest reproducibility of size and yield, which
may indicate that hydrodynamic confounders caused by slight
differences in feed point position were introduced between
experiments. Surprisingly, no significant differences were
observed for polydispersity with stirring, suggesting that, in
the static system, size distribution was controlled by diffusion-
limited or polynuclear surface-controlled growth.54 The
moderate polydispersity of all formulations arose, in part,
due to the time dependence of antisolvent composition, the
local regions of high supersaturation at the droplet−antisolvent
interface, and the nonuniform nucleation inherent in the semi-
batch process. Although particle size was affected, the zeta
potential remained at a constant level as stirring rate was
varied, suggesting that packing geometries were affected by
active stirring although the secondary structure content
remained consistent.
Particle growth is a thermodynamically driven process and
primarily occurs via three diffusion-limited mechanisms:
stepwise growth52 proceeding through molecular adsorption
until the equilibrium silk saturation concentration is reached;
Ostwald ripening,57 whereby the dissolution of small particles
results in the growth of larger particles; and aggregation
proceeding according to Smoluchowski kinetics.27 The rate of
silk nanoparticle growth was also investigated over 24 h by
varying the standing time in the mother liquor before
purification. No significant differences in nanoparticle phys-
icochemical properties, yield (Figure 2), or secondary structure
content (Figure 3c) were observed for standing times between
0 and 24 h.
The isoelectric point of crystalline silk fibroin lies between
pH 4 and 5.58 Therefore, silk nanoparticles and silk molecules
in the mother liquor have a net negative surface charge. This
results in repulsive long-range electrostatic interactions
between nanoparticles, providing a high-energy barrier for
aggregation and agglomeration and conferring colloidal
stability. These repulsive interactions exist between nano-
particles, precursor silk molecules, and newly formed silk
nuclei. Hence, once silk nanoparticles reach a key size, they no
longer act as templates for stepwise growth, as the repulsive
energy barrier and entropic loss are no longer offset by the
establishment of favorable short-range bonds and reduction in
surface energy. The conversion of amorphous content to β-
sheet structure upon nanoprecipitation can also be considered
irreversible at room temperature, in the absence of chaotropic
agents.20 The tightly bound crystalline architecture, poor
solubility of the silk hydrophilic blocks in the mother liquor,
and the low polydispersity of nanoparticle size consequently
result in unfavorable nanoparticle growth via Ostwald ripening.
This means that screening of operating conditions for
nanoparticle manufacture at room temperature can be
conducted with maximum time efficiency, increasing through-
put.
For example, at 6 mL scale and 0 h standing time, the
nanoparticle production rate was estimated as 0.41 g/h using
semi-automated silk dispensing and 0.12 g/h using manual silk
addition, assuming 23% nanoparticle yields.20 The former
value assumed the use of one syringe pump equipped with two
syringes, while both processes require an operator intensive
setup time of 1 min. Based on this, the time taken to prepare
nanoparticle batches for conducting a clinically relevant in vivo
study with five rats was calculated. Assuming a nanoparticle
blood concentration7 of 250 μg mL−1 and a rat blood volume
of 25.6 mL, 6.4 mg of silk nanoparticles would be required per
rat. The time taken to obtain the total required mass of 32 mg
is 0.08 and 0.26 h using the semi-automated and manual
setups, respectively. However, the total production rate is
lowered by the 6 h purification process, assuming the use of
one eight-place centrifuge. Nevertheless, the total production
rate can be increased by a syringe pump platform and
centrifuge parallelization.
The characterization of the effect of aging on nanoparticle
physicochemical properties is important for maximizing shelf
life and preventing undesired complications. For this reason,
we also examined the long-term stability of silk nanoparticles
from all formulations in aqueous conditions for over 1 month
at 4 °C to assess storage capabilities (Figure 5). Similar to
previous studies,13,20,32 the zeta potential of nanoparticles from
all formulations on the day of manufacture was lower than −25
mV, indicating sufficient electrostatic repulsion between
particles for moderate aqueous stability. Indeed, silk nano-
particles manufactured across all stirring rates and standing
times showed size stability over the entire study period. Some
fluctuations in polydispersity and zeta potential occurred for
nanoparticles produced from some formulations and, while
these changes were significant, they did not follow a trend
indicative of time-dependent flocculation, coagulation, or
dissolution.32 This observation was reinforced by morpho-
logical assessments conducted over the time course by SEM,
which showed spherical granules without apparent agglomer-
ation or adhesion (Figure 6). The sizes of the freeze-dried
particles imaged by SEM were relatively small compared to the
Z-average size measured using DLS, probably due to the
removal of the solvation sphere and bound water during freeze-
drying.50
5. CONCLUSIONS
The use of a semi-automated liquid dispensing setup provided
consistent, standardized, and higher-throughput manufacture
of silk nanoparticles via drop-by-drop desolvation in a semi-
batch format. Operational parameters investigated for their
effect on nanoparticle formation indicated that decreasing the
initial addition height from 7.5 to 5.5 cm reduced the
nanoparticle yield. The stirring rate was also a key process
parameter that affected silk nanoparticle size, yield, and
experiment reproducibility, as stirring at 400 rpm provided
the smallest nanoparticle size and the lowest yield of silk
nanoparticles. Nanoparticles from all formulations displayed
spherical morphologies and showed stability of size and
polydispersity for over 1 month when stored as aqueous
suspensions at 4 °C. The standing time of silk nanoparticles in
the mother liquor was also not a key process parameter, and
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time-efficient manufacture can be achieved at room temper-
ature.
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